99 related articles for article (PubMed ID: 22121430)
41. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.
Iljazović E; Mena M; Tous S; Alemany L; Omeragić F; Sadiković A; Clavero O; Vergara M; Bosch FX; de Sanjosé S
Cancer Epidemiol; 2014 Oct; 38(5):504-10. PubMed ID: 25130915
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
[TBL] [Abstract][Full Text] [Related]
43. HPV types and cofactors causing cervical cancer in Peru.
Santos C; Muñoz N; Klug S; Almonte M; Guerrero I; Alvarez M; Velarde C; Galdos O; Castillo M; Walboomers J; Meijer C; Caceres E
Br J Cancer; 2001 Sep; 85(7):966-71. PubMed ID: 11592767
[TBL] [Abstract][Full Text] [Related]
44. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models.
Reimers LL; Anderson WF; Rosenberg PS; Henson DE; Castle PE
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):792-800. PubMed ID: 19258470
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019-2023 compared to 2003-2008.
Sivars L; Holzhauser S; Ramqvist T; Tham E; Hellman K; Dalianis T
Acta Oncol; 2023 Dec; 62(12):1649-1652. PubMed ID: 37793801
[TBL] [Abstract][Full Text] [Related]
46. Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.
Chen AA; Gheit T; Franceschi S; Tommasino M; Clifford GM;
J Virol; 2015 Oct; 89(20):10680-7. PubMed ID: 26269181
[TBL] [Abstract][Full Text] [Related]
47. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].
Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374
[TBL] [Abstract][Full Text] [Related]
48. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
49. [Human papillomavirus types in women with cervical cancer in Haifa District].
Siegler E; Lahat N; Shiner M; Mackuli L; Aroudi Y; Shapiro S; Auslander R; Lavie O
Harefuah; 2011 Nov; 150(11):837-41, 876. PubMed ID: 22428203
[TBL] [Abstract][Full Text] [Related]
50. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma.
Khan S; Jaffer NN; Khan MN; Rai MA; Shafiq M; Ali A; Pervez S; Khan N; Aziz A; Ali SH
Int J Infect Dis; 2007 Jul; 11(4):313-7. PubMed ID: 17291804
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha.
Ahmed MI; Salahy EE; Fayed ST; El-Hefnawy NG; Khalifa A
Clin Biochem; 2001 Sep; 34(6):491-8. PubMed ID: 11676979
[TBL] [Abstract][Full Text] [Related]
53. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
54. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
55. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
Berraho M; Amarti-Riffi A; El-Mzibri M; Bezad R; Benjaafar N; Benideer A; Matar N; Qmichou Z; Abda N; Attaleb M; Znati K; El Fatemi H; Bendahhou K; Obtel M; Filali Adib A; Mathoulin-Pelissier S; Nejjari C
BMC Cancer; 2017 Jun; 17(1):435. PubMed ID: 28633667
[TBL] [Abstract][Full Text] [Related]
56. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.
Kwasniewska A; Postawski K; Gozdzicka-Jozefiak A; Kwasniewski W; Grywalska E; Zdunek M; Korobowicz E
Oncol Rep; 2011 Jul; 26(1):153-60. PubMed ID: 21491087
[TBL] [Abstract][Full Text] [Related]
57. Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
Cocco E; Varughese J; Buza N; Bellone S; Glasgow M; Bellone M; Todeschini P; Carrara L; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Lockwood CJ; Santin AD
BMC Cancer; 2011 Jun; 11():263. PubMed ID: 21693061
[TBL] [Abstract][Full Text] [Related]
58. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands.
Bulk S; Berkhof J; Bulkmans NW; Zielinski GD; Rozendaal L; van Kemenade FJ; Snijders PJ; Meijer CJ
Br J Cancer; 2006 Jan; 94(1):171-5. PubMed ID: 16404371
[TBL] [Abstract][Full Text] [Related]
59. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
[TBL] [Abstract][Full Text] [Related]
60. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies.
International Collaboration of Epidemiological Studies of Cervical Cancer
Int J Cancer; 2007 Feb; 120(4):885-91. PubMed ID: 17131323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
